Voloridge Investment Management, LLC Catalyst Pharmaceuticals, Inc. Transaction History
Voloridge Investment Management, LLC
- $26.2 Billion
- Q2 2024
A detailed history of Voloridge Investment Management, LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Voloridge Investment Management, LLC holds 754,725 shares of CPRX stock, worth $15.1 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
754,725
Previous 1,083,037
30.31%
Holding current value
$15.1 Million
Previous $17.3 Million
32.28%
% of portfolio
0.04%
Previous 0.06%
Shares
12 transactions
Others Institutions Holding CPRX
# of Institutions
285Shares Held
96.6MCall Options Held
29.2KPut Options Held
20.5K-
Black Rock Inc. New York, NY18.7MShares$373 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY9.13MShares$182 Million2.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.1MShares$162 Million0.0% of portfolio
-
State Street Corp Boston, MA6.03MShares$120 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3MShares$59.9 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.05B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...